The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Celldex
Stock and Other Ownership Interests - Celldex
A phase 2, multicenter, open-label study to evaluate the efficacy and safety of CDX-3379 in combination with cetuximab in patients with advanced head and neck squamous cell carcinoma (HNSCC).
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; Kolltan Pharmaceuticals; Merck; Merck Serono
Research Funding - AVEO; Bristol-Myers Squibb; Genentech; Lilly; Merck; VentiRx
 
Nabil F. Saba
Honoraria - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Pfizer
 
Douglas Adkins
Consulting or Advisory Role - Merck; Pfizer
Research Funding - AstraZeneca (Inst); Biothera (Inst); Celgene (Inst); Celldex (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Ying Wang
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Yi He
No Relationships to Disclose
 
Elsa Paradise
Employment - Celldex
 
Roger B. Cohen
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks
Research Funding - Celldex (Inst); Cleave Biosciences (Inst); Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks